ArticleACS medicinal chemistry letters2022

Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors.

Dmitriy Shcherbakov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.